LIVZON PHARMA (01513) Nominates Liu Daping and Tang Yanggang as Executive Director Candidates

Stock News

04/23

LIVZON PHARMA (01513) announced that, as the term of the company's 11th board of directors is set to expire on June 20, 2026, the board has conducted a thorough review and unanimously agreed to nominate Mr. Zhu Baoguo, Mr. Lin Nanqi, and Mr. Qiu Qingfeng as candidates for non-executive directors of the 12th board of directors. The board also nominated Mr. Liu Daping and Mr. Tang Yanggang as candidates for executive directors of the 12th board of directors. Furthermore, following careful deliberation, the board unanimously agreed to nominate Mr. Luo Huiyuan, Ms. Cui Lijie, Ms. Kang Li, and Ms. Wang Zhiyao as candidates for independent directors of the 12th board of directors.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1157874721"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157874721\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157874721?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 20:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157874721","market":"nz","top_or_hot":-1,"title":"LIVZON PHARMA (01513) Nominates Liu Daping and Tang Yanggang as Executive Director Candidates","media":"Stock News","content":"<p>LIVZON PHARMA (01513) announced that, as the term of the company's 11th board of directors is set to expire on June 20, 2026, the board has conducted a thorough review and unanimously agreed to nominate Mr. Zhu Baoguo, Mr. Lin Nanqi, and Mr. Qiu Qingfeng as candidates for non-executive directors of the 12th board of directors. The board also nominated Mr. Liu Daping and Mr. Tang Yanggang as candidates for executive directors of the 12th board of directors. Furthermore, following careful deliberation, the board unanimously agreed to nominate Mr. Luo Huiyuan, Ms. Cui Lijie, Ms. Kang Li, and Ms. Wang Zhiyao as candidates for independent directors of the 12th board of directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVZON PHARMA (01513) Nominates Liu Daping and Tang Yanggang as Executive Director Candidates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVZON PHARMA (01513) Nominates Liu Daping and Tang Yanggang as Executive Director Candidates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-23 20:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LIVZON PHARMA (01513) announced that, as the term of the company's 11th board of directors is set to expire on June 20, 2026, the board has conducted a thorough review and unanimously agreed to nominate Mr. Zhu Baoguo, Mr. Lin Nanqi, and Mr. Qiu Qingfeng as candidates for non-executive directors of the 12th board of directors. The board also nominated Mr. Liu Daping and Mr. Tang Yanggang as candidates for executive directors of the 12th board of directors. Furthermore, following careful deliberation, the board unanimously agreed to nominate Mr. Luo Huiyuan, Ms. Cui Lijie, Ms. Kang Li, and Ms. Wang Zhiyao as candidates for independent directors of the 12th board of directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1157874721","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157874721","pubTimestamp":1776946601,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LIVZON PHARMA (01513) announced that, as the term of the company's 11th board of directors is set to expire on June 20, 2026, the board has conducted a thorough review and unanimously agreed to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","01513":"丽珠医药"},"translate_title":"丽珠医药(01513)提名刘大平、唐仰刚为执行董事候选人","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"LIVZON PHARMA (01513) announced that, as the term of the company's 11th board of directors is set to expire on June 20, 2026, the board has conducted a thorough review and unanimously agreed to nominate Mr. Zhu Baoguo, Mr. Lin Nanqi, and Mr. Qiu Qingfeng as candidates for non-executive directors of the 12th board of directors. The board also nominated Mr. Liu Daping and Mr. Tang Yanggang as candidates for executive directors of the 12th board of directors. Furthermore, following careful deliberation, the board unanimously agreed to nominate Mr. Luo Huiyuan, Ms. Cui Lijie, Ms. Kang Li, and Ms. Wang Zhiyao as candidates for independent directors of the 12th board of directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}